Fusion Pharmaceuticals Inc.
Focus: Fusion Pharmaceuticals is a public-stage biopharmaceutical company headquartered in Hamilton, Ontario, specializing in targeted alpha therapeutics for chemo-resistant cancers. The company focuses on oncology and neurology indications with a differentiated radiotherapy platform.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Fusion Pharmaceuticals Inc.
AI assessmentNot HiringNo open roles listed right now. Follow Fusion Pharmaceuticals Inc. to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
18 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
LOE Approaching
Legacy NDA product with antimicrobial indication; approaching loss of exclusivity signals commoditization and limited revenue contribution to core oncology strategy.
Products & Portfolio (1)
Help build intelligence for Fusion Pharmaceuticals Inc.
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.